Cpxm2 as a novel candidate for cardiac hypertrophy and failure in hypertension.
Grabowski K, Herlan L, Witten A, Qadri F, Eisenreich A, Lindner D, Schädlich M, Schulz A, Subrova J, Mhatre KN, et al. Hypertens Res. 2022 Feb; 45(2):292-307. Epub 2021 Dec 16.